Daniel L. Davenport

Daniel L. Davenport

Auto-generated profile, based on publicly available information

Daniel L. Davenport

Department of Surgery, University of Kentucky, Lexington, Kentucky

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Journal of Surgical Research
Verified
Journal Article
Closed access
CTCrystal F. Totten
Crystal F. Totten
DDDaniel L. Davenport
Daniel L. Davenport
NWNicholas D. Ward
Nicholas D. Ward
JRJ. Scott Roth
J. Scott Roth

1 October 2019 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
CHChris Harryman
Chris Harryman
MPMargaret A Plymale
Margaret A Plymale
ESEvan Stearns
Evan Stearns
DDDaniel L. Davenport
Daniel L. Davenport
WCWayne Chang
Wayne Chang
JFJohn Scott Roth, MD, FACS
John Scott Roth, MD, FACS

4 September 2013 in Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
BZBrittany A. Zwischenberger
Brittany A. Zwischenberger
MBMary M. Beasley
Mary M. Beasley
DDDaniel L. Davenport
Daniel L. Davenport
EXEleftherios S. Xenos
Eleftherios S. Xenos
Purpose: To determine whether a correlation exists between chronic cerebrospinal venous insufficiency (CCSVI) and multiple sclerosis (MS). Materials and Methods: A meta-analysis of the current literature was performed to evaluate the frequency of CCSVI, diagnosed by echo color Doppler criteria, in patients with MS and in normal controls. Results: In all, 19 studies were identified from January 2005 through February 2013; however, 3 studies were excluded due to duplicate data and 3 additional studies because 0 patients fulfilled CCSVI criteria in both MS and control groups. In order to improve homogeneity, 4 outlier studies were also removed from the analysis. Analysis of the remaining 9 studies demonstrated a significant correlation between CCSVI and MS (odds ratio 1.885, P < .0001) with no significant heterogeneity of the studies ( I2 = 18, P = .279). Conclusions: The meta-analysis demonstrated a correlation between CCSVI and MS. However, there was no evidence that CCSVI has a causative role in MS.

1 June 2014 in The American Surgeon™
Verified
Journal Article
Open access
PDF file
KLKristin L. Long
Kristin L. Long
DHDavid A. Hamilton
David A. Hamilton
DDDaniel L. Davenport
Daniel L. Davenport
ABAndrew C. Bernard
Andrew C. Bernard
PKPaul A. Kearney
Paul A. Kearney
PCPhillip K. Chang
Phillip K. Chang
Dramatic increases in damage control and decompressive laparotomies and a significant increase in patients with open abdominal cavities have resulted in numerous techniques to facilitate fascial closure. We hypothesized addition of the abdominal reapproximation anchor system (ABRA) to the KCI Abdominal Wound Vac™ (VAC) or KCI ABThera™ would increase successful primary closure rates and reduce operative costs. Fourteen patients with open abdomens were prospectively randomized into a control group using VAC alone (control) or a study group using VAC plus ABRA (VAC-ABRA). All patients underwent regular VAC changes; patients receiving VAC-ABRA also underwent concomitant daily elastomer adjustment of the ABRA system. Primary end points included abdominal closure, number of operating room (OR) visits, and OR time use. Eight patients were included in the VAC-ABRA group and six patients in the control group. Primary closure rates between groups were not statistically different; however, the number of trips to the OR and OR time use were different. Despite higher Acute Physiology and Chronic Health Evaluation II scores, larger starting wound size, and higher rates of abdominal compartment syndrome, closure rates in the VAC-ABRA group were similar to VAC alone. Importantly, however, fewer OR trips and less OR time were required for the VAC-ABRA group.

1 December 2016 in Clinical Nephrology
Verified
Journal Article
Open access
PAPaul Anaya
Paul Anaya
GBGustav Blomquist
Gustav Blomquist
DDDaniel Davenport
Daniel Davenport
MMMarie-Claude Monier-Faugere
Marie-Claude Monier-Faugere
VSVincent Sorrell
Vincent Sorrell
HMHartmut Malluche
Hartmut Malluche
Coronary artery calcification (CAC) is common in patients with chronic kidney disease on hemodialysis (CKD-5D) and is an important predictor of mortality. However, cardiac functional links between CAC and mortality have not been well established. This study tested the hypothesis that CAC increases mortality by adversely affecting cardiac function. Patients were recruited from 37 regional dialysis centers. 2-D and Doppler echocardiographic analyses were performed, and CAC was measured using 64-slice computed tomography. Relationships between CAC and echocardiographic measures of left ventricular (LV) function were analyzed. Survival was assessed with median follow-up of 37 months. There were 157 patients: 59% male, 46% Caucasian, 48% diabetic. Median age was 55 years, and median duration of CKD-5D was 45 months. Agatston CAC scores 100 were found in 69% of patients, with 51% having a score 400. CAC was associated with measures of LV systolic and diastolic function (global longitudinal strain (GLS; rho = 0.270, p = 0.004)), peak LV systolic velocity (rho = -0.259, p = 0.004), and estimate of LV filling pressure (E:E'; rho = 0.286, p = 0.001). Multivariate regression confirmed these relationships after adjustment for age, gender, LV ejection fraction, and coronary artery disease. Valvular calcification varied linearly with CAC (p < 0.05). Both LV diastolic and systolic functional measures were significant predictors of mortality, the strongest of which was LV diastolic dysfunction. These findings show a link between CAC, cardiac function, and mortality in CKD-5D. LV diastolic function (E:E'), peak LV systolic velocity, and GLS are independent predictors of mortality. Valvular calcification may be an important marker of CAC in CKD-5D. These effects on cardiac function likely explain the high mortality with CKD-5D and describe a potentially-valuable role for echocardiography in the routine management of these patients. .

1 April 2021 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
JWJames W. Warwick
James W. Warwick
DDDaniel L. Davenport
Daniel L. Davenport
ABAmber Bettis
Amber Bettis
ABAndrew C. Bernard
Andrew C. Bernard
BACKGROUND: This study analyzed data from the 2017 American College of Surgeons National Trauma Data Bank to examine the effects of pre-hospital Field Triage Decision Scheme Step 1 vital sign criteria (S1C) and vital sign decline on subsequent emergency department (ED) and hospital death in emergency medical services (EMS) transported trauma victims. STUDY DESIGN: Patient and injury characteristics, transport time, and ED and hospital disposition were collected. S1C (respiratory rate [RR]29 breaths/min, systolic blood pressure [SBP]<90 mmHg, Glasgow Coma Scale [GCS]<14) were recorded at the injury scene and hospital arrival. Decline was defined as a change ≥ 1 standard deviation (SD) into or within an S1C range. S1C and decline were analyzed relative to ED and hospital death using logistic regression. RESULTS: Of 333,213 included patients, 54,849 (16.5%) met Step 1 criteria at the scene, and 21,566 (6.9%) declined en route. The ED death rate was 0.4% (n = 1,188), and the hospital death/hospice rate was 4.0% (11,624 of 287,675). Patients who met S1C at the scene or who declined were more likely to require longer hospital lengths of stay, ICU admission, and surgical intervention. S1C and decline patients had higher odds of death in both the ED (S1C odds ratio [OR] 15.1, decline OR 2.4, p values < 0.001) and hospital (S1C OR 4.8, decline OR 2.0, p values < 0.001) after adjusting for patient demographics, transport time and mode, injury severity, and injury mechanism. Each S1C and decline measure was independently predictive of death. CONCLUSIONS: This study quantifies the mortality risks associated with individual S1C and validates their use as an indicator for injury severity and pre-hospital triage tool.